SAN DIEGO — Alida Biosciences today announced the launch of its EpiPlex™ Tri-Mod™ Service, enabling simultaneous detection and quantification of three key mRNA modifications—N6-methyladenosine (m6A), inosine, and pseudouridine—together with RNA expression profiling in a single workflow. The service expands researchers’ ability to study RNA-level regulation, an increasingly important but underexplored driver of disease biology across a wide […]
OBERKOCHEN, Germany — Revolune, a new life science company focused on enabling clearer insights from complex biological systems, today announced its official launch. The company is dedicated to advancing spatial biology through streamlined multiplex immunofluorescence (mIF) reagents designed to deliver reliable, efficient, and scalable tissue analysis workflows for translational and biopharma research. Modern biomedical research […]
New extraction-to-library prep workflow enables highly accurate long-read sequencing from archived clinical samples, expanding opportunities in cancer research MENLO PARK, Calif. and WOBURN, Mass. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, and Covaris, a PerkinElmer company and leader in sample preparation technologies, today announced a joint workflow has been […]
The Content Innovation Engine brings together Akoya’s spatial biology platform and Quanterix’s immunoassay infrastructure to systematically unlock cancer biology and accelerate the path toward clinical application BILLERICA, Mass. — Quanterix Corporation (Nasdaq: QTRX) today announced plans to debut its Content Innovation Engine at the American Association for Cancer Research (AACR) Annual Meeting 2026. Built on the integration […]
ArgusEye AB today announce the appointment of Sofia Håkansson Buch as its new Chief Executive Officer (CEO), marking an important step in the company’s next phase of growth. With a strong background in biopharma, Sofia will lead the company’s continued growth and commercialization of its real-time bioprocess monitoring platform. Sofia brings extensive experience from the […]
New Offering Integrates DOPPL’s Patient-Derived Intestinal Organoid Technology with InSphero’s Proven Standardized Screening Model Schlieren, Switzerland – InSphero AG, the global leader in 3D cell-based assays and organ-on-chip systems, today announced the commercial launch of the 3D InSight™ Drug-Induced Gastrointestinal Toxicity (DIGIT) platform, a standardized, high-throughput screening solution for early assessment of gastrointestinal liabilities in drug discovery. […]
Phase two collaboration aims to expand access to streamlined genomic workflows for infectious disease research Oxford Nanopore Technologies, the company delivering a new generation of nanopore-based molecular sensing technology for real-time genomic analysis, and Cepheid, a Danaher company and a leader in molecular diagnostics for infectious diseases, have announced an expansion of their partnership to […]
Lightcast Raises $27 Million and Adds Industry Veteran to Accelerate Commercialization of Envisia ™Platform · Proceeds will help enhance workflows and expand single-cell functional assay portfolio · Brad Crutchfield joins as advisor to support early access growth and global launch CAMBRIDGE, England – Lightcast, a pioneering life science tools company focused on functional single-cell analysis, today announced […]
Boulder, CO – Watchmaker Genomics, an innovator in high-performance tools for molecular diagnostic (MDx) assay developers, today announced the expansion of its MDx tools portfolio with the launch of Stellar RT-qPCR and qPCR Kits. Together with Watchmaker’s Recombinase Polymerase Amplification (RPA) enzyme suite, the portfolio now enables assay developers to design across both PCR and isothermal modalities to […]
Development of novel Ankyrons will enable study of emerging high-consequence infectious diseases to inform vaccines and treatments OXFORD, UK — ProImmune, Ltd., a global leader in immunological reagents and services, today announced a collaboration with The University of Texas Medical Branch (UTMB) Galveston National Laboratory (GNL), a high-containment, infectious disease research facility, to develop innovative tools […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
